Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

The measurement of urinary hydroxyurea in sickle cell anaemia.

Dalton RN, Turner C, Dick M, Height SE, Awogbade M, Inusa B, Okpala I, O'Driscoll S, Thein SL, Rees DC.

Br J Haematol. 2005 Jul;130(1):138-44.

PMID:
15982356
2.

Plasma and urine hydroxyurea levels might be useful in the management of adult sickle cell disease.

Bachir D, Hulin A, Huet E, Habibi A, Nzouakou R, El Mahrab M, Astier A, Galacteros F.

Hemoglobin. 2007;31(4):417-25.

PMID:
17994375
3.

Enalapril and hydroxyurea therapy for children with sickle nephropathy.

Fitzhugh CD, Wigfall DR, Ware RE.

Pediatr Blood Cancer. 2005 Dec;45(7):982-5.

PMID:
15704213
4.

Sickle cell patients find a brand New World.

Noonan SS.

N J Med. 1999 Aug;96(8):23-5.

PMID:
10457727
5.

Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy.

Ware RE, Eggleston B, Redding-Lallinger R, Wang WC, Smith-Whitley K, Daeschner C, Gee B, Styles LA, Helms RW, Kinney TR, Ohene-Frempong K.

Blood. 2002 Jan 1;99(1):10-4.

6.

Hydroxyurea therapy for sickle cell disease in community-based practices: a survey of Florida and North Carolina hematologists/oncologists.

Zumberg MS, Reddy S, Boyette RL, Schwartz RJ, Konrad TR, Lottenberg R.

Am J Hematol. 2005 Jun;79(2):107-13.

7.

Hydroxyurea for children with sickle cell disease.

Heeney MM, Ware RE.

Pediatr Clin North Am. 2008 Apr;55(2):483-501, x. doi: 10.1016/j.pcl.2008.02.003. Review.

PMID:
18381097
8.

Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.

Al-Jam'a AH, Al-Dabbous IA.

Saudi Med J. 2002 Mar;23(3):277-81.

PMID:
11938415
9.

The association of oral hydroxyurea therapy with improved cognitive functioning in sickle cell disease.

Puffer E, Schatz J, Roberts CW.

Child Neuropsychol. 2007 Mar;13(2):142-54.

PMID:
17364571
10.

Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease.

Zimmerman SA, Schultz WH, Davis JS, Pickens CV, Mortier NA, Howard TA, Ware RE.

Blood. 2004 Mar 15;103(6):2039-45. Epub 2003 Nov 20.

11.

[Evaluation of clinical response by hydroxyurea in 132 patients with major sickle cell anemia].

Elira Dokekias A, Okandze Elenga JP, Ndinga J, Sanogo I, Sangare A.

Tunis Med. 2005 Jan;83(1):32-7. French.

PMID:
15881719
12.

The role of hydroxyurea in the management of sickle cell disease.

Davies SC, Gilmore A.

Blood Rev. 2003 Jun;17(2):99-109. Review.

PMID:
12642122
13.

Circulating endothelin-3 levels in patients with sickle cell disease during hydroxyurea treatment.

Makis AC, Hatzimichael EC, Kolios G, Bourantas KL.

Haematologica. 2004 Mar;89(3):360-1.

14.

Cytotoxic and genotoxic monitoring of sickle cell anaemia patients treated with hydroxyurea.

Khayat AS, Antunes LM, Guimarães AC, Bahia MO, Lemos JA, Cabral IR, Lima PD, Amorim MI, Cardoso PC, Smith MA, Santos RA, Burbano RR.

Clin Exp Med. 2006 Mar;6(1):33-7.

PMID:
16550342
15.

Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.

Dahoui HA, Hayek MN, Nietert PJ, Arabi MT, Muwakkit SA, Saab RH, Bissar AN, Jumaa NM, Farhat FS, Dabbous IA, Bitar FF, Abboud MR.

Pediatr Blood Cancer. 2010 Mar;54(3):398-402. doi: 10.1002/pbc.22306.

PMID:
19827138
16.

Hydroxyurea therapy: improving the lives of patients with sickle cell disease.

Anderson N.

Pediatr Nurs. 2006 Nov-Dec;32(6):541-3. Review.

PMID:
17256291
17.

Hydroxyurea for sickle cell anemia.

Bachmeyer C, Aractingi S, Lionnet F.

N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9. No abstract available.

PMID:
18609755
18.

Two assays to evaluate potential genotoxic effects of hydroxyurea in sickle cell disease patients.

Rodríguez A, Kouegnigan L, Ferster A, Cotton F, Duez P.

Hemoglobin. 2012;36(6):545-54. doi: 10.3109/03630269.2012.725688. Epub 2012 Oct 24.

PMID:
23094637
19.

Population pharmacokinetics of hydroxyurea for children and adolescents with sickle cell disease.

Wiczling P, Liem RI, Panepinto JA, Garg U, Abdel-Rahman SM, Kearns GL, Neville KA.

J Clin Pharmacol. 2014 Sep;54(9):1016-22. doi: 10.1002/jcph.303. Epub 2014 Apr 11.

PMID:
24729271
20.

Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.

Covas DT, de Lucena Angulo I, Vianna Bonini Palma P, Zago MA.

Haematologica. 2004 Mar;89(3):273-80.

Supplemental Content

Support Center